14-O-Heterocyclic-substituted naltrexone derivatives as non-peptide mu opioid receptor selective antagonists: Design, synthesis, and biological studies

Схожие документы

• Design, Syntheses, and Biological Evaluation of 14-Heteroaromatic Substituted Naltrexone Derivatives: Pharmacological Profile Switch from Mu Opioid Receptor Selectivity to Mu/Kappa Opioid Receptor Dual Selectivity
  по: Yuan, Yunyun, et al.
  Опубликовано: (2013)
• Design, Synthesis, and Biological Evaluation of 6α- and 6β-N-Heterocyclic Substituted Naltrexamine Derivatives as μ Opioid Receptor Selective Antagonists
  по: Li, Guo, et al.
  Опубликовано: (2009)
• Characterization of 6α- and 6β-N-Heterocyclic Substituted Naltrexamine Derivatives as Novel Leads to Development of Mu Opioid Receptor Selective Antagonists
  по: Yuan, Yunyun, et al.
  Опубликовано: (2011)
• Binding Mode Characterization of 6α- and 6β-N-Heterocyclic Substituted Naltrexamine Derivatives via Docking in Opioid Receptor Crystal Structures and Site-directed Mutagenesis Studies: Application of the “Message–Address” Concept in Development of Mu Opioid Receptor Selective Antagonists
  по: Zaidi, Saheem A., et al.
  Опубликовано: (2013)
• Opioid receptor selectivity profile change via isosterism for 14-O-substitued naltrexone derivatives
  по: Zhang, Yan, et al.
  Опубликовано: (2013)